After the presentations of diabetes and new onsets after vaccination, almost all of the patients presenting with either ketoacidosis or fulminant T1DM have recovered and well managed through insulin infusions, achieving good glycemic control, so the benefits of the vaccination outweigh their side effects. This evidence concerns the gene INS and type 1 diabetes mellitus.